Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Dysplastic naevus
ADR ID BADD_A08651
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.26      Cutaneous neoplasms benign
16.26.01      Skin neoplasms benign
16.26.01.011      Dysplastic naevus
23      Skin and subcutaneous tissue disorders
23.10      Cutaneous neoplasms benign
23.10.01      Skin neoplasms benign
23.10.01.011      Dysplastic naevus
Description Clinically atypical nevi (usually exceeding 5 mm in diameter and having variable pigmentation and ill defined borders) with an increased risk for development of non-familial cutaneous malignant melanoma. Biopsies show melanocytic dysplasia. Nevi are clinically and histologically identical to the precursor lesions for melanoma in the B-K mole syndrome. (Stedman, 25th ed) [MeSH]
MedDRA Code 10062805
MeSH ID D004416
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Dysplastic nevus | Dysplastic naevus | Dysplastic Nevus Syndrome | Nevus Syndrome, Dysplastic | Syndrome, Dysplastic Nevus | B-K Mole Syndrome | B K Mole Syndrome | Syndrome, B-K Mole | Familial Atypical Multiple Mole-Melanoma | Familial Atypical Multiple Mole Melanoma | Dysplastic Nevi | Dysplastic Nevus | Nevi, Dysplastic | Nevus, Dysplastic
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00195Azathioprine0.002154%
BADD_D00898Finasteride0.000214%
BADD_D02105Tacrolimus0.001419%
BADD_D02344Vemurafenib0.000433%
BADD_D02464Fingolimod0.012159%
The 1th Page    1    Total 1 Pages